Amedisys Inc AMED shares are up Monday after the company announced that it received an unsolicited proposal from Optum, a diversified health services company, to acquire all of the outstanding shares of Amedisys' common stock. The proposal, made on May 26, 2023, was for an all-cash transaction for $100 per share.
What To Know: On May 3, 2023, it was announced that Amedisys entered into a merger agreement with Option Care Health, Inc. OPCH. The merger would combine the companies in an all-stock transaction and give Amedisys stockholders 3.0213 shares of Option Care Health common stock for each existing share of Amedisys common stock they hold at the closing of the transaction.
As permitted by the terms of Amedisys' merger agreement with Option Care Health, Amedisys entered into a confidentiality agreement with Optum on May 30, 2023. Exploratory discussions are currently being engaged in with Optum regarding the proposal.
Related Link: Why Portage Biotech Stock Is Up Today
AMED Price Action: Shares of AMED were up 14.5% at $90.97 at the time of publication, according to Benzinga Pro.
Image by svklimkin from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.